TheraFluor
- Biotech or pharma, animal health
- Biotech or pharma, therapeutic R&D
- Diagnostics
TheraFluor, Inc. is a privately held theranostic company pioneering the targeted use of innovative nanomedicines to improve health outcomes for cancer patients. The company is developing a cutting-edge technology platform for cancer detection, fluorescence-guided surgery (FGS), and phototherapy (PT), designed to maximize patient benefits while minimizing side effects. Headquartered in Portland, Oregon, TheraFluor was founded on intellectual property from Oregon State University and is working to bring its proprietary nanoparticle technology and specialized instruments to both human and veterinary medicine markets. TheraFluor has assembled a talented team with deep expertise in biotechnology, fluorescent chemistry, regulatory affairs, and market strategy. We have also assembled a strong advisory network, including key inventors, veterinary experts, and collaborators at Oregon State University. For more information, visit www.therafluor.com.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}